WO1999060410A1 - Method and apparatus for background surveillance and detection of unsuspected aberrant clinical information - Google Patents
Method and apparatus for background surveillance and detection of unsuspected aberrant clinical information Download PDFInfo
- Publication number
- WO1999060410A1 WO1999060410A1 PCT/IB1999/000900 IB9900900W WO9960410A1 WO 1999060410 A1 WO1999060410 A1 WO 1999060410A1 IB 9900900 W IB9900900 W IB 9900900W WO 9960410 A1 WO9960410 A1 WO 9960410A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- test
- group
- tests
- results
- analyzer
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/00584—Control arrangements for automatic analysers
- G01N35/00594—Quality control, including calibration or testing of components of the analyser
- G01N35/00603—Reinspection of samples
Definitions
- the method and apparatus includes the performance of a single test or the performance of continuous testing and monitoring of a patient.
- the method and apparatus are further useful as a quality control measurement tool.
- Fig. 1 is a flow chart of the method of the present invention
- Fig. 2 is a flow chart of an additional embodiment of the method of the present invention
- Fig. 3 is a print out of a first display screen showing the test selection portion of a particular embodiment of the present invention
- Fig. 4 is a print out of a second display screen directing that aspiration of the sample be started
- Fig. 5 is a print out of a third display screen showing the aspiration time for taking the sample
- Fig. 6 is a print out of a fourth display screen directing that the aspiration of the sample be halted
- Fig. 7 is a print out of a fifth display screen showing the entry of patient/sample data
- Fig. 8 is a print out of a sixth display screen showing the results of the testing as the testing of the sample is being run;
- Fig. 9 is a print out of a seventh display screen showing that an alarm limit has been exceeded and asking whether this information should be displayed;
- Fig. 10 is a print out of an eighth display screen showing the results being displayed including the results for the unselected test
- Fig. 11 is a print out of a ninth display screen showing the test results for all the selected tests.
- Fig. 12 is a flow chart of a quality control method of the present invention.
- An analyzer or other sample testing device can provide a plurality of tests of a sample, for example a blood analyzer can provide tests for the tHb, pO2, pH etc., of a blood sample taken from a patient.
- a blood analyzer can provide tests for the tHb, pO2, pH etc., of a blood sample taken from a patient.
- a physician while require only a subset of the available tests. While only a subset of tests are determined to be of particular relevance by the physician, there may be other tests which would show a condition not originally thought to be existing in the sample being tested.
- the presently disclosed method and apparatus allows for a physician to select the tests thought to be most relevant and further provides the ability to monitor the output of other unselected tests should the results of these unselected tests meet a predetermined threshold, thus indicating an aberrant condition which typically requires immediate attention.
- a flow chart of a first embodiment 1 of the presently disclosed method is shown.
- the presently disclosed method is useful for the detection of unsuspected carbon monoxide poisoning caused by an improperly functioning heating system or other combustion source.
- a patient presents himself to an emergency room of a hospital complaining of fatigue and headaches.
- These symptoms in this instance are rather non-specific and are associated with a wide variety of disorders.
- alarm thresholds are defined for at least one of the plurality of available tests the analyzer can perform.
- the defined alarm thresholds when exceeded, indicate that that an aberrant condition exists which requires immediate attention.
- a selection is made by the physician as to which test results are to be reported. These test results will be reported to the physician irregardless of whether the selected tests have had alarm thresholds defined or if these alarm thresholds have been exceeded.
- the attending physician in this example may order a general blood screen in an attempt to identify the underlying cause of the symptoms experienced by the patient. The blood sample taken from the patient is then tested on the analyzer utilizing the method of the present invention.
- step 120 recites that the selected tests are run on the sample, and the tests which were not selected but have had threshold limits defined are also run on the sample, although these tests which were not selected but have had threshold limits defined are run in the background.
- the physician has not elected to test for hemoglobin fractions as part of the testing operations selected, however an alarm threshold has been defined earlier for the different hemoglobin parameters.
- This alarm threshold may be a pre-established generic threshold, or a threshold specifically defined by the physician.
- a determination is made as to whether any alarm thresholds of the unselected tests have been exceeded by the measurement of the sample.
- the test results for the selected tests and for the tests that have had their alarm thresholds exceeded are reported to the physician, even though these tests were not originally selected by the physician, as shown in step 140. If no alarm thresholds were exceeded on the unselected tests, then the results of the selected tests are reported, as shown in step 150. After the reporting of the selected tests results and any tests results that were not selected but exceeded their predetermined threshold, the testing of the sample is finished, as shown in step 160. In this instance the alarm threshold for carboxyhemoglobin level has been exceeded and is reported to the physician who is alerted to what could be or may be a life threatening situation if left undiscovered.
- PEEP Positive End Expiratory Pressure
- a second embodiment 200 of the presently disclosed invention is shown generally in Fig. 2 and more particularly in Figs. 3-11.
- the method 200 is similar to the method 100 of Fig. 1 but allows the physician to consciously elect not to view parameters for which the results were not originally desired, but which the alarm threshold limit is exceeded. This may be useful in certain clinical procedures where the value is expected to be abnormal, such as in the period following administration of cardioplegic solutions.
- alarm thresholds are defined for at least one of the plurality of available tests the analyzer can perform. The alarm thresholds, when exceeded, indicate that that an aberrant condition exists which requires immediate attention.
- the next step 110' shows that a selection is made by the physician as to which test results are to be reported.
- Shown in Fig. 3 is a printout of a first display screen 400. This screen shows that a sample is going to be tested. The screen further shows that the testing of the sample for pH, pC0 2 , p0 2 , Na + , K + , Ca ++ , GLU and HCT are selected. The testing for the level of Cl " has not been selected. An alarm limit has previously been defined for a level of Cl " .
- Fig. 4 shows a second display screen 410 which directs the clinician to insert the syringe containing the sample material into the analyzer to begin aspiration of the sample.
- Fig. 3 shows a printout of a first display screen 400. This screen shows that a sample is going to be tested. The screen further shows that the testing of the sample for pH, pC0 2 , p0 2 , Na + , K + , Ca ++ , GLU
- FIG. 5 shows the display screen 420 where the aspiration of the sample material from the syringe is timed.
- Fig. 6 show the display screen 430 which directs the clinician to remove the syringe from the analyzer thereby ending the aspiration of the sample.
- Fig. 7 shows the display screen 440 where the patient and sample information is entered. The following step, step 120', recites that the selected tests are run on the sample, and that the tests which were not selected but have had threshold limits assigned are also run on the sample.
- Fig. 8 shows the display screen 450 which shows the testing being performed on the sample. The ongoing results for the testing of Cl " level are not shown since that test was not selected, however the testing for Cl " level is actually occurring in the background.
- a display screen 460 is shown. This screen indicates that a safety alarm limit (also known as SAFETY NET TM) has been exceeded and questions the clinician as to whether this information, even though originally not selected, should be displayed to the clinician. If the clinician desires to see the unselected test results than the YES box is selected; if the clinician does not desire to see the unselected test results the NO box is selected.
- a safety alarm limit also known as SAFETY NET TM
- step 140' the results of the selected tests and the results of the unselected tests that exceeded the alarm threshold limit are reported.
- Selection of the YES box shows the test results as shown in Fig. 10.
- the results of the Cl " testing are shown along with the other selected tests results.
- the selected test results are reported without reporting any of the unselected tests results.
- Selection of the NO box shows the results as shown in Fig. 11.
- the display screen 480 shows only the test results for the selected tests and does not show the results for the unselected test even though the alarm limit for that test had been exceeded.
- the testing is then finished, as shown in step 160'.
- the present invention may additionally be utilized as part of a quality control measurement system.
- a set of counters are provided which keep track of the number of times different tests which were unselected by the physician as part of the diagnosis of a patient's condition had their alarm threshold exceeded. If a high rate of this situation occurs for a particular physician, then the physician can be notified and a determination made as to why this is occurring. For example if a certain physician is constantly having results reported which are not requested, it may indicate that the physician needs to be aware of checking for a broader range of causes related to certain symptoms or that the physician is lacking in proper clinical knowledge with respect to testing for certain conditions given a particular set of symptoms.
- an overall count can be maintained and observed on a timely basis to ensure that proper testing is being requested at appropriate times by comparing results month to month. If too small a number of thresholds alarm are being reported, than the doctors may be ordering too many tests. On the other hand, if a larger than usual number occurs, then the physician may need to prescribe more tests. As such, a level of quality control can be monitored and maintained.
- the counters utilized for quality control are initialized as shown in step 310.
- alarm thresholds are defined for at least one of the plurality of available tests the analyzer can perform. The defined alarm thresholds, when exceeded, indicate that that an aberrant condition exists which requires immediate attention.
- a selection is made by the physician as to which test results are to be reported. These test results will be reported to the physician irregardless of whether the selected tests have had alarm thresholds defined or if these alarm thresholds have been exceeded.
- step 120 recites that the selected tests are run on the sample, and the tests which were not selected but have had threshold limits defined are also run on the sample.
- the selected tests are run on the sample in the foreground, while the unselected tests which include a respective predefined threshold limit are executed in the background.
- An automated analyzer is typically utilized to perform testing of a sample to determine characteristics of the sample.
- the automated analyzer is under control of a programmable processor which is coupled to a memory and to a user interface.
- the analyzer is capable of performing a plurality of tests on the sample. A user of the analyzer selects a first group of tests from the available tests to be run on the sample. Previous to this, certain ones of the plurality of tests may have had threshold limits defined. The selected tests are run on the sample under the control of the analyzer.
- the analyzer While the selected tests are being run in the foreground, the analyzer is additionally running the unselected tests which have had threshold limits defined in the background.
- the user interface does not make the user aware that the unselected tests which have had threshold limits exceeded are in fact being run.
- the analyzer When the analyzer has completed the testing of the sample, the user is provided with the tests results via the user interface. Additionally, the analyzer reports via the user interface the results of any of the unselected tests which were run in the background if the respective threshold limit was exceeded.
- the analyzer instead of reporting the results of any of the unselected tests which had an alarm threshold exceeded for a respective test, questions the user as to whether the user desires to view the results of any unselected tests which have had an alarm threshold exceeded. The user responds either yes or no via the user interface. If the user indicated that the results were desired, the analyzer provides the results to the user. If the results are not desired, the analyzer then does not report the unselected test results.
Landscapes
- Engineering & Computer Science (AREA)
- Quality & Reliability (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000549971A JP2002520684A (en) | 1998-05-21 | 1999-05-19 | Method and apparatus for background investigation and detection of unexpected abnormal clinical information |
AU36237/99A AU3623799A (en) | 1998-05-21 | 1999-05-19 | Method and apparatus for background surveillance and detection of unsuspected aberrant clinical information |
CA002332773A CA2332773A1 (en) | 1998-05-21 | 1999-05-19 | Method and apparatus for background surveillance and detection of unsuspected aberrant clinical information |
EP99918224A EP1080372A1 (en) | 1998-05-21 | 1999-05-19 | Method and apparatus for background surveillance and detection of unsuspected aberrant clinical information |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8259898A | 1998-05-21 | 1998-05-21 | |
US09/082,598 | 1998-05-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999060410A1 true WO1999060410A1 (en) | 1999-11-25 |
Family
ID=22172179
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB1999/000900 WO1999060410A1 (en) | 1998-05-21 | 1999-05-19 | Method and apparatus for background surveillance and detection of unsuspected aberrant clinical information |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1080372A1 (en) |
JP (1) | JP2002520684A (en) |
AU (1) | AU3623799A (en) |
CA (1) | CA2332773A1 (en) |
WO (1) | WO1999060410A1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4517160A (en) * | 1979-04-14 | 1985-05-14 | Olympus Optical Company Limited | Automatic analyzing apparatus |
EP0307882A2 (en) * | 1987-09-18 | 1989-03-22 | E.I. Du Pont De Nemours And Company | Immunological switch for controlling the reporting of test results |
US5631844A (en) * | 1991-07-30 | 1997-05-20 | University Of Virginia | Interactive remote sample analysis system |
US5749907A (en) * | 1997-02-18 | 1998-05-12 | Pacesetter, Inc. | System and method for identifying and displaying medical data which violate programmable alarm conditions |
-
1999
- 1999-05-19 WO PCT/IB1999/000900 patent/WO1999060410A1/en not_active Application Discontinuation
- 1999-05-19 EP EP99918224A patent/EP1080372A1/en not_active Withdrawn
- 1999-05-19 JP JP2000549971A patent/JP2002520684A/en not_active Withdrawn
- 1999-05-19 AU AU36237/99A patent/AU3623799A/en not_active Abandoned
- 1999-05-19 CA CA002332773A patent/CA2332773A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4517160A (en) * | 1979-04-14 | 1985-05-14 | Olympus Optical Company Limited | Automatic analyzing apparatus |
EP0307882A2 (en) * | 1987-09-18 | 1989-03-22 | E.I. Du Pont De Nemours And Company | Immunological switch for controlling the reporting of test results |
US5631844A (en) * | 1991-07-30 | 1997-05-20 | University Of Virginia | Interactive remote sample analysis system |
US5749907A (en) * | 1997-02-18 | 1998-05-12 | Pacesetter, Inc. | System and method for identifying and displaying medical data which violate programmable alarm conditions |
Also Published As
Publication number | Publication date |
---|---|
AU3623799A (en) | 1999-12-06 |
CA2332773A1 (en) | 1999-11-25 |
JP2002520684A (en) | 2002-07-09 |
EP1080372A1 (en) | 2001-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101938939B (en) | Apparatus for measuring and predicting patients' respiratory stability | |
US10248762B2 (en) | System and method of medical device alarm management | |
EP1913383B1 (en) | Meter having multi-level user interface | |
EP1133256B1 (en) | A diagnostic tool using a predictive instrument | |
US9211096B2 (en) | Real time clinical decision support system having medical systems as display elements | |
US6277071B1 (en) | Chronic disease monitor | |
US8936555B2 (en) | Real time clinical decision support system having linked references | |
US20030225315A1 (en) | Data analysis system | |
US20120278099A1 (en) | Monitoring, capturing, measuring and annotating physiological waveform data | |
CN112424872A (en) | Predictive medical device maintenance management | |
JP2007287144A (en) | Case based outcome prediction in real-time monitoring system | |
CN101203172A (en) | An apparatus to measure the instantaneous patients acuity value | |
EP3937769A1 (en) | Determining reliability for egg data using signal-to-noise ratio | |
Garibaldi et al. | The evaluation of an expert system for the analysis of umbilical cord blood | |
WO1999060410A1 (en) | Method and apparatus for background surveillance and detection of unsuspected aberrant clinical information | |
US20040153340A1 (en) | Method for monitoring telemedicine healthcare services | |
WO2014182677A1 (en) | Real time clinical decision support system having medical systems as display elements | |
US11298087B2 (en) | Method and system for predicting physiological alarm frequency by patient monitors | |
US20230335290A1 (en) | System and methods for continuously assessing performance of predictive analytics in a clinical decision support system | |
EP3460808A1 (en) | Determining patient status based on measurable medical characteristics | |
Tang et al. | Why Is a Rule-based Shock Early Warning System Not Accurate: a Case Study | |
CN118098461A (en) | Clinical patient state monitoring method and system based on artificial intelligence | |
CN117594180A (en) | Method for displaying medical data and life information processing system | |
CN115881256A (en) | Offline evaluation method and device | |
Powell | The development of computerised continuous and multi-modality monitoring in the intensive care environment of a district general hospital |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999918224 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2332773 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 1999918224 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999918224 Country of ref document: EP |